Topiramate Capsule, Coated Pellets
Product Images NDC 68382-004

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68382-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

8170d851 7b5c 46cd 937f 6cf331cc820e 01

8170d851 7b5c 46cd 937f 6cf331cc820e 01
Chemical structure of topiramate, showing the arrangement of atoms and bonds including carbon, oxygen, sulfur, nitrogen, and hydrogen elements in the molecule.*
FDA Label Image

8170d851 7b5c 46cd 937f 6cf331cc820e 02

8170d851 7b5c 46cd 937f 6cf331cc820e 02
A line graph displaying cumulative rates for time to first seizure over a time period up to 500 days, comparing two dosages of topiramate: 50 mg/day and 400 mg/day. The x-axis represents time in days, and the y-axis represents cumulative rates. The graph includes separate curves for each dosage level and a statistical significance value (P = 0.0002).*
FDA Label Image

8170d851 7b5c 46cd 937f 6cf331cc820e 03

8170d851 7b5c 46cd 937f 6cf331cc820e 03
A bar graph showing changes from baseline to double-blind phase in average monthly migraine period rate with topiramate at doses 50 mg/day, 100 mg/day, and 200 mg/day compared to placebo. Data from two studies (Study 11 and Study 12) are represented, indicating greater reductions in migraine rate at higher doses of topiramate compared to placebo.*
FDA Label Image

8170d851 7b5c 46cd 937f 6cf331cc820e 04

8170d851 7b5c 46cd 937f 6cf331cc820e 04
Topiramate Capsules, USP 15 mg label from Zydus Pharmaceuticals USA Inc. The label shows the product name, dosage strength (15 mg), capsule count (60), prescription-only status (Rx only), and instructions for pharmacists to dispense the Medication Guide. Additional labeling includes storage instructions, drug safety warnings, manufacturer and distributor information, and a barcode on a white background with purple and teal accent colors.*
FDA Label Image

8170d851 7b5c 46cd 937f 6cf331cc820e 05

8170d851 7b5c 46cd 937f 6cf331cc820e 05
Topiramate Capsules, USP 25 mg coated pellets in a capsule. The label shows a quantity of 60 capsules, prescription use only, manufactured by Zydus Pharmaceuticals USA Inc. The label includes dosage details and storage instructions, with NDC 68382-005-14. It has a purple, pink, and black color scheme with the Zydus logo and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.